Exemestane ZPHC — 25 mg × 100 tablets

$69.00

Exemestane (Aromasin®) — irreversible steroidal AI

100 film-coated tablets × 25 mg

  • Mechanism: permanently deactivates aromatase, lowering estrogen by ≈ 85 % and boosting endogenous testosterone.
  • Research uses: post-cycle therapy, estrogen-dependent breast cancer models, mitigation of gynecomastia & water retention.
  • Dose guide (research): 12.5 mg EOD for mild E2 control · 25 mg EOD during high-aromatase cycles · 25 mg daily × 2 weeks in PCT protocols.
  • Lipid support: monitor HDL/LDL; consider omega-3 or niacin supplementation.
  • QC: ≥ 99 % API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.

*For laboratory research use only. Not approved as a medicinal product.*

Available Options
Quantity
Category:

Exemestane ZPHC — 25mg

100 Film-Coated Tablets

Exemestane ZPHC is a steroidal aromatase inhibitor (AI) commonly referenced in:

  • Estrogen-regulation research
  • Endocrine-response studies
  • Hormonal pathway analysis
  • Post-cycle hormonal recovery models

Exemestane functions as an:

  • Irreversible aromatase inhibitor
  • Estrogen-suppression compound
  • Steroidal AI research agent

The product is supplied as:

  • 100 film-coated tablets
  • 25mg per tablet

Product Specifications

Specification Details
Manufacturer ZPHC
Active Ingredient Exemestane
Classification Steroidal Aromatase Inhibitor
Strength 25mg per tablet
Presentation 100 film-coated tablets
Form Oral tablets
Quality Standard ≥99% API purity (HPLC)
Manufacturing GMP-compliant tablet press
Authentication Scratch-code verification

Compound Profile

Aromatase Inhibition Research

Exemestane is commonly associated with:

  • Aromatase enzyme suppression studies
  • Estrogen-regulation pathway analysis
  • Hormonal balance and endocrine-response research

Estrogen-Control Studies

Research literature frequently references:

  • Water-retention mitigation analysis
  • Estrogen-related tissue response models
  • Hormonal recovery pathway studies

Precision Tablet Delivery

The tablet format supports:

  • Standardized dosing consistency
  • Controlled laboratory protocols
  • Predictable release characteristics

Key Features

Irreversible Steroidal AI

  • Permanently binds and deactivates aromatase enzymes in research models
  • Frequently referenced in estrogen-control studies

High-Purity Manufacturing

  • ≥99% HPLC-verified purity
  • GMP manufacturing standards

Secure Authentication System

  • Tamper-evident packaging
  • Scratch-code authenticity verification
  • Controlled batch-traceability standards

Safety Information

Potential adverse effects associated with aromatase inhibitor exposure may include:

  • Joint discomfort or dryness
  • Fatigue or reduced energy levels
  • Mood changes
  • Reduced estrogen-related protective effects
  • Lipid profile alterations
  • Bone-density concerns with prolonged exposure

Improper or unsupervised hormone modulation may increase endocrine and cardiovascular risks.

Important Medical Guidance

Hormone-related compounds should only be used:

  • Under supervision of a qualified healthcare professional
  • With appropriate hormone and lipid monitoring
  • According to local medical regulations and prescription laws

Misuse may result in serious health complications.

Storage Instructions

Condition Recommendation
Temperature Store in a cool, dry place
Moisture Protect from humidity
Light Exposure Keep away from direct sunlight
Safety Keep out of reach of children

 

Reviews

There are no reviews yet.

Be the first to review “Exemestane ZPHC — 25 mg × 100 tablets”

Your email address will not be published. Required fields are marked *

Shopping Cart
Scroll to Top